Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients

2006 ◽  
Vol 172 (1-2) ◽  
pp. 166-174 ◽  
Author(s):  
Y SUZUKI ◽  
H ONODERA ◽  
H TAGO ◽  
R SAITO ◽  
M OHUCHI ◽  
...  
2005 ◽  
Vol 170 (1-2) ◽  
pp. 172-178 ◽  
Author(s):  
Ryuji Saito ◽  
Hiroshi Onodera ◽  
Hideaki Tago ◽  
Yasushi Suzuki ◽  
Masayuki Shimizu ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Merve Çebi ◽  
Hacer Durmus ◽  
Fikret Aysal ◽  
Berker Özkan ◽  
Gizem Engin Gül ◽  
...  

1999 ◽  
Vol 190 (8) ◽  
pp. 1115-1122 ◽  
Author(s):  
Lucy S.K. Walker ◽  
Adam Gulbranson-Judge ◽  
Sarah Flynn ◽  
Thomas Brocker ◽  
Chandra Raykundalia ◽  
...  

Mice rendered deficient in CD28 signaling by the soluble competitor, cytotoxic T lymphocyte–associated molecule 4–immunoglobulin G1 fusion protein (CTLA4-Ig), fail to upregulate OX40 expression in vivo or form germinal centers after immunization. This is associated with impaired interleukin 4 production and a lack of CXC chemokine receptor (CXCR)5 on CD4 T cells, a chemokine receptor linked with migration into B follicles. Germinal center formation is restored in CTLA4-Ig transgenic mice by coinjection of an agonistic monoclonal antibody to CD28, but this is substantially inhibited if OX40 interactions are interrupted by simultaneous injection of an OX40-Ig fusion protein. These data suggest that CD28-dependent OX40 ligation of CD4 T cells at the time of priming is linked with upregulation of CXCR5 expression, and migration of T cells into B cell areas to support germinal center formation.


1997 ◽  
Vol 10 (2) ◽  
pp. 203-217 ◽  
Author(s):  
Raghavanpillai Raju ◽  
Duraiswamy Navaneetham ◽  
Maria Pia Protti ◽  
Robert M. Horton ◽  
Bobbi L. Hoppe ◽  
...  

2020 ◽  
Vol 216 ◽  
pp. 108462
Author(s):  
Xiaoxi Liu ◽  
Qian Ma ◽  
Li Qiu ◽  
Changyi Ou ◽  
Zhongqiang Lin ◽  
...  

Blood ◽  
2002 ◽  
Vol 100 (1) ◽  
pp. 159-166 ◽  
Author(s):  
Philipp Ströbel ◽  
Markus Helmreich ◽  
Georgios Menioudakis ◽  
Sharon R. Lewin ◽  
Thomas Rüdiger ◽  
...  

Abstract Myasthenia gravis (MG) is the leading paraneoplastic manifestation of thymomas and is probably related to the capacity of thymomas to mature and export potentially autoreactive T cells. Why some thymomas are MG associated (MG+) and others are not (MG−) has been unclear. We addressed this question by comparing the percentages of intratumorous naive mature CD45RA+ thymocytes in 9 MG(+) and in 13 MG(−) thymomas by fluorescence-activated cell sorting analysis. Our results show that intratumorous naive CD4 T cells were present in all MG(+) thymomas and in one MG(−) thymoma with the development of MG only 2 months after surgery. By contrast, the percentage of naive CD4+ T cells was significantly reduced in all 13 MG(−) thymomas (P < .0001). Alterations in intratumorous thymopoiesis were reflected by corresponding alterations of naive T-cell subset composition in the blood, in that only MG(−) patients had significantly decreased levels (P = .02) of naive CD4+ T cells compared with age- and sex-matched control persons. We conclude that paraneoplastic MG is highly associated with the efficiency of thymomas to produce and export naive CD4+T cells. The acquisition of the CD45RA+ phenotype on CD4+ T cells during terminal intratumorous thymopoiesis is associated with the presence of MG in most thymoma patients.


Sign in / Sign up

Export Citation Format

Share Document